| NCT ID | NCT07342335 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Clatterbridge Cancer Centre NHS Foundation Trust |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-11-29 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-11-29 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is a need to improve accessibility to research and clinical trials within the NHS. Key groups are consistently under-represented in research: those from minority ethnic backgrounds, those with lower socio-economic status and those with impaired capacity. This leads to inequality of healthcare and an inequality of patient experience. Increasing access to research would not only broaden research opportunities and bridge gaps in health equality; diverse research representation means better understanding of disease mechanisms and greater generalisability of findings across the patient population. There are well described socio-economic issues across the region that this trust serves within Cheshire and Merseyside. This brings health challenges for patients. Clatterbridge Cancer Centre is a large networked cancer centre serving Cheshire and Merseyside using a hub model. Research is a core strategic theme; it is hugely important that it is understood not only the areas and hotspots of cancer across the region, but also that patients with those cancers can access a portfolio of research that serves a distinct patient need. Currently there is a lack of such triangulated information within the Trust, which may mean that patient need remains unmet. Therefore the research is designed to understand any barriers that patients may have in accessing research, in tandem with a demographic review and mapping of patient referral and access to the current trials portfolio. This will lead to a truly patient centred approach in accessing research.
Eligibility Criteria
Inclusion Criteria: * Adults over 18 years. No upper age limit * A confirmed diagnosis of cancer * Patient planned to or is receiving treatment at The Clatterbridge Cancer Centre NHS Foundation Trust * Able to provide informed consent Exclusion Criteria: * Patients with severe co-morbidities considered by the screening team to interfere with the individual's ability to complete requirements of the study or to provide informed consent.
Frequently Asked Questions
Who can join the NCT07342335 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07342335 currently recruiting?
Yes, NCT07342335 is actively recruiting participants. Visit ClinicalTrials.gov or contact The Clatterbridge Cancer Centre NHS Foundation Trust to inquire about joining.
Where is the NCT07342335 trial being conducted?
This trial is being conducted at Liverpool, United Kingdom.
Who is sponsoring the NCT07342335 clinical trial?
NCT07342335 is sponsored by The Clatterbridge Cancer Centre NHS Foundation Trust. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.